Proposal to fund lisdexamfetamine for the treatment of attention deficit hyperactivity disorder (ADHD)
By thomas
26 September 2024
26 September 2024
- About us
- Members1
- Audit tools
- Business tools
- ICPSA tools
- Member advice lines
- Member discounts
- Newsletters
- Online clinical resources
- Patient counselling resources
- Pharmacy practice resources
- Pharmacy services
- Posters, signs, and marketing resources
- Quality improvement tools
- Sector advocacy
- Workplace requirements
- Join1